论文部分内容阅读
本月全球药品研发进展取得成效的药物共有71个,比上月大幅增加22个。进入注册阶段的有35个,较上月增加14个。其中,11个为全球首次注册的药品,在新市场补充注册的为24个。进入注册前阶段的有6个,较上月增加1个。进入Ⅲ期临床研究阶段的有30个,较上月增加7个。
There were 71 drugs that made progress in global pharmaceutical research and development this month, a sharp increase of 22 from the previous month. 35 have entered the registration phase, an increase of 14 from the previous month. Among them, 11 were the first drugs registered in the world and 24 were newly registered in the new market. There were six before entering the registration phase, an increase from the previous month. Into the phase Ⅲ clinical research phase of 30, an increase of 7 last month.